NCT04765865 Evaluating Implementation and Scale-Up of Nigeria's National Sodium Reduction Program
| NCT ID | NCT04765865 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Washington University School of Medicine |
| Condition | Dietary Sources of Sodium |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,350 participants |
| Start Date | 2023-06-26 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,350 participants in total. It began in 2023-06-26 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The NaSS aims to assess the extent to which the SHAKE program is implemented within Nigeria by the Nigerian Agency for Food and Drug Administration and Control (NAFDAC) using a type III hybrid, mixed method study design.
Eligibility Criteria
Inclusion Criteria: * Male and female adults (aged 18 to 69 years) * Willingness to participate * Permanent residents (a person who has been in the household for at least 6 months) of the study area * Ability to provide informed consent Exclusion Criteria: * Individuals who are unable to provide informed consent * Pregnant women, and those who are breastfeeding and/or women menstruating at the time of collection * Cognitively impaired adults * Those with known history of heart or kidney failure, stroke, liver disease * Those who recently began therapy with diuretics (less than two weeks) * Any other conditions that would make 24-hour urine collection difficult * Individuals who are not yet adults (minors): i.e. infants, children, or teenagers \<18 years old * Prisoners or other detained individuals
Contact & Investigator
Mark D Huffman, MD, MPH
PRINCIPAL INVESTIGATOR
Washington University School of Medicine
Frequently Asked Questions
Who can join the NCT04765865 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 69 Years, studying Dietary Sources of Sodium. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04765865 currently recruiting?
Yes, NCT04765865 is actively recruiting participants. Contact the research team at guhaniyer@wustl.edu for enrollment information.
Where is the NCT04765865 trial being conducted?
This trial is being conducted at Abeokuta, Nigeria, Gwagwalada, Nigeria, Kano, Nigeria.
Who is sponsoring the NCT04765865 clinical trial?
NCT04765865 is sponsored by Washington University School of Medicine. The principal investigator is Mark D Huffman, MD, MPH at Washington University School of Medicine. The trial plans to enroll 1,350 participants.